Medtronic landed an FDA approval for its myPTM smartphone-powered controller for the SynchroMed II drug delivery system. The new product allows pain patients with the implanted SynchroMed II device to deliver a bolus of the medication into their bodies, precisely when needed. The patient’s physician can set limits on how much of the drug can (Read more...)